December 7, 2016
Eselior names Laurent Vahcerot president and COO
Essilor, a medical supplies company, has decided to realign its organization to meet the growing operational needs as the company…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
December 7, 2016
GeNeuro, Servierhave extend multiple sclerosis study
GeNeuro and Servierhave set up a study they named ANGEL-MS, which is a long-term extension study for patients with multiple sclerosis…
December 2, 2016
Amryt loans from EIB for skin disorder gel aimed for $1.5 billion market
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
November 10, 2016
Allergan announces launch of birth control capsules
Allergan has announced the availability of TAYTULLATM (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules)…
November 10, 2016
BD and JDRF join forces to fight type 1 diabetes
BD has announced a new research collaboration supported by JDRF, the global organization funding…
November 10, 2016
Lifeline Scientific leaves AIM due to merger with Shanghai Genext
The merger of Lifeline Scientific with Shanghai Genext Medical Technology and certain of its affiliates dated September 1, 2016, is…
November 10, 2016
Bristol-Myers to develop Nitto's investigational anti-fibrosis drug
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
November 10, 2016
The European Patent Office approves Akers Biosciences' Breath Ketone Detector
The European Patent Office has issued a patent covering the Akers Biosciences’ Breath Ketone Detector, a single-use, non-invasive, breath device…
November 10, 2016
Comprehensive loss for Probiodrug in the third quarter of 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
November 10, 2016
Catalyst Pharmaceuticals finishes Q3 2016 with net loss
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating …